Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 93
Filter
1.
Eur J Cancer Care (Engl) ; 27(2): e12753, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28921733

ABSTRACT

Studies exploring the mediating and predictive factors of anxiety and depression for prostate cancer patients in Eastern countries are scant. Guided by the transactional model of stress and coping, this study determined the predictors and mediators of anxiety and depression in prostate cancer patients. The participants comprised 115 prostate cancer patients and 91 partners. The patients and partners completed questionnaires regarding physical symptoms, disease appraisals, coping behaviours, anxiety and depression in the period before confirmation of treatment decisions and 1, 3, 6 and 12 months after treatment. The results revealed that partner anxiety engendered a stressful situation and aggravated patient anxiety. Patients' threat appraisals and affective-oriented coping behaviours mediated the relationships between their anxiety levels and those of their partners. The patients' most recent prostate-specific antigen (PSA) levels and hormonal symptoms were key predictors of their anxiety and depression levels. The patients' harm appraisals mediated the relationships between their most recent PSA levels and hormonal symptoms and depression. Their threat appraisals and affective-oriented coping behaviours mediated the relationships between their hormonal symptoms and anxiety and depression. To manage those key factors, reframing, appraising disease and improving coping behaviours may reduce anxiety and depression levels in prostate cancer patients.


Subject(s)
Anxiety Disorders/etiology , Depressive Disorder/etiology , Prostatic Neoplasms/psychology , Spouses/psychology , Adaptation, Psychological , Aged , Aged, 80 and over , Humans , Longitudinal Studies , Male , Middle Aged , Prospective Studies , Risk Factors , Stress, Psychological/etiology , Taiwan
2.
J Small Anim Pract ; 57(11): 626-630, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27726133

ABSTRACT

OBJECTIVE: The clinical feasibility of passive immunotherapy has not been demonstrated in dogs naturally infected with canine distemper. In this study, porcine anti-canine distemper virus IgG and F(ab')2 antibody fragments were used to treat infected puppies. METHODS: A total of 41 naturally infected puppies (age Äsix months) exhibiting severe respiratory signs, but lacking neurological signs, were enrolled in the study. Twenty-five puppies were treated with a combination of IgG or F(ab')2 antibody fragments (Group 1) and supportive therapy and 16 puppies received routine supportive care only (Group 2). RESULTS: The survival rate of dogs in Group 1 (19/25; 76%) was significantly higher than that in Group 2 (5/16; 31·3%) (P<0·05). During the therapy, 8 of the 25 dogs (32%) in Group 1 developed neurological signs versus 12 of the 16 dogs (75%) in Group 2 (P<0·05). Adverse reactions were limited to elevated body temperature in dogs that received IgG antibodies. CLINICAL SIGNIFICANCE: Porcine anti-canine distemper virus antibodies improved survival in puppies affected with canine distemper with minimal adverse effects. Therefore, this therapy could be considered for treatment of endangered animal species infected with canine distemper virus.


Subject(s)
Antibodies, Heterophile/immunology , Antibodies, Viral/immunology , Distemper Virus, Canine/immunology , Distemper/prevention & control , Viral Vaccines/administration & dosage , Animals , Animals, Newborn , Dogs , Female , Male , Treatment Outcome , Vaccination/veterinary
3.
Eur Surg ; 45(2): 106-109, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23637707

ABSTRACT

BACKGROUND: Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is a rare disease and mostly occurs in females, and there are only three male cases described in the literatures without long-term follow-up. CASE REPORT: A 59-year-old male presented with a left retroperitoneal cystic mass (7.5 ´ 7 ´ 3 cm) that upwardly displaced the left kidney and caused abdominal discomfort. The tumor was totally excised by the hand-assisted laparoscopic method without complications or recurrence in a follow-up period of 79 months. The etiology from coelomic metaplasia of peritoneal epithelium was proved by a spectrum of diverse cells (benign, borderline malignant, and malignant cells) during pathological examination. RESULTS: This is the fourth male case of PRMC in the world with a favorable outcome after hand-assisted laparoscopic excision, and this is also distinct by the longest follow-up period in this disease entity. CONCLUSIONS: Because of its low-malignant potential and recurrence rate, surgical excision is still the best choice of treatment, but the least invasion method should be adopted in front.

4.
Clin Nephrol ; 76(5): 412-6, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22000563

ABSTRACT

We report a 79-year-old woman with a left side simple renal cyst invaded by infiltrating urothelial carcinoma mimicking a Bosniak Class IV renal cyst. Computerized tomography has high accuracy for the diagnosis of renal cysts and urothelail carcinoma. But, in this case it was still difficult to distinguish a simple renal cyst with infiltrating urothelial carcinoma invasion from a Bosniak Class IV renal cyst on CT scan. The management of a Bosniak Class IV renal cyst and urothelail carcinoma is totally different. Therefore, we performed a left side nephroureterectomy. This patient will have regular follow-up with cystoscopy every 3 months for the first 2 y, every 6 months for the next 2 y, and then annually thereafter.


Subject(s)
Carcinoma, Transitional Cell/diagnostic imaging , Kidney Diseases, Cystic/diagnostic imaging , Kidney Neoplasms/diagnostic imaging , Aged , Carcinoma, Transitional Cell/pathology , Carcinoma, Transitional Cell/surgery , Diagnosis, Differential , Female , Humans , Kidney Diseases, Cystic/pathology , Kidney Diseases, Cystic/surgery , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Neoplasm Invasiveness , Nephrectomy/methods , Radiography
5.
Br J Cancer ; 103(6): 852-60, 2010 Sep 07.
Article in English | MEDLINE | ID: mdl-20736946

ABSTRACT

BACKGROUND: Parvin-beta (ParvB), a potential tumour suppressor gene, is a focal adhesion protein. We evaluated the role of ParvB in the upper urinary tract urothelial cell carcinoma (UUT-UC). METHODS: ParvB mRNA and proteins levels in UUT-UC tissue were investigated by quantitative real-time polymerase chain reaction and western blot analysis, respectively. In addition, the expression of ParvB in tissues from patients with UUT-UC at different stages was evaluated by immunohistochemistry. Furthermore, biological functions of ParvB in urothelial cancer cells were investigated using a doxycycline-inducible overexpression system and siRNA. RESULTS: Western blot and mRNA analysis showed downregulation of ParvB expression in frozen UUT-UC tissue. Immunohistochemistry revealed high staining intensity of ParvB in normal urothelium, which decreased markedly at advanced stages of UUT-UC (P=0.0000). Moreover, ParvB was an independent prognostic indicator for disease-specific survival of patients with UUT-UC. Functional assays indicated that overexpression of ParvB in an urothelial cancer cell line resulted in decreased cell growth rate and ability to migrate. In contrast, knockdown of ParvB expression increased cell migration ability. CONCLUSIONS: Downregulation of ParvB expression significantly increased urothelial cancer cell growth and migration. Downexpression of ParvB level in UUT-UC correlated with tumour stage, and was an independent unfavourable prognostic factor for disease-specific survival of patients with UUT-UC.


Subject(s)
Actinin/metabolism , Biomarkers, Tumor/metabolism , Urinary Bladder Neoplasms/metabolism , Urothelium/pathology , Actinin/chemistry , Actinin/genetics , Base Sequence , Blotting, Western , Cell Division/physiology , Cell Movement/physiology , DNA Primers , Gene Knockdown Techniques , Humans , Immunohistochemistry , Prognosis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Survival Analysis , Urinary Bladder Neoplasms/pathology
6.
Int J Clin Pract ; 63(2): 292-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19196367

ABSTRACT

AIMS: To determine whether visibility of ureteral calculi on plain radiographs of the kidney, ureter and bladder (KUB) could be predicted based on characteristics on unenhanced helical computed tomography (UHCT) and CT scout radiographs (CTSR). METHODS: One hundred and twenty-three patients diagnosed with 140 ureteral calculi on UHCT, had undergone both UHCT and KUB within 24 h and before calculus passage or intervention were included. The visibility of ureteral calculi on KUB and CTSR as well as their sizes, locations and densities on UHCT were recorded. The association of CTSR/UHCT characteristics of ureteral calculi and their visibility on KUB were analysed. Multivariate analyses using logistic regression were computed as predictors for visibility on KUB. RESULTS: Of the 140 calculi, 56 (40%) and 98 (70%) were visible on CTSR and KUB respectively. All calculi detectable on CTSR were also visible on KUB. Multivariate analyses of the 84 CTSR undetectable calculi revealed that non-middle ureteral location and higher calculi densities on UHCT were significant predictors of visibility on KUB. All non-middle ureteral calculi with density > 800 Hounsfield units (HU) were visible on KUB. Of 23 calculi in the middle ureter or with density < 200 HU, 17 (74%) were invisible on KUB. CONCLUSIONS: Ureteral calculi characteristics on UHCT and CTSR are useful for predicting their visibility on KUB. Patients with visible calculi on CTSR or non-middle ureteral calculi with density > 800 HU are suitable for KUB to follow-up calculi status.


Subject(s)
Tomography, Spiral Computed/methods , Tomography, X-Ray Computed/methods , Ureteral Calculi/diagnostic imaging , Adult , Aged , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies , Young Adult
8.
Theriogenology ; 69(6): 758-66, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-18258292

ABSTRACT

A cDNA microarray-assisted experiment was conducted to survey genes that respond early to heat shock in enriched immature porcine germ cells; the 5'-UTR flanking the highest upregulated gene, heat shock 105/110 kDa protein 1 (Hsph1 or Hsp105), in response to heat shock was also investigated. We established a porcine testis cDNA microarray with 9944 transcripts from two libraries constructed from the testes of mature boars, with or without heat shock. After a mild heat shock treatment (39 degrees C for 1h and recovered at 34 degrees C for 2h), 380 transcripts demonstrated significant gene expression in enriched immature germ cells; 326 were upregulated and 54 were downregulated. Ten transcripts of interest exhibiting significance analysis of microarrays (SAM) scores higher than the median were subjected to quantitative real-time PCR; three (Hsp105, Hspa4l and Thap4) were upregulated >1.5-fold. The sequence of the 5'-UTR of Hsp105, the highest upregulated transcript, was cloned and analyzed. A single nucleotide polymorphism (SNP) was found at position -762 (C or T) upstream of the translational start site (ATG codon). Only two genotypes (CC or TC) were found in the mature boars that were studied (n=31). A heterozygous genotype (TC) at this SNP site revealed an elevated percentage of morphologically normal sperm during hot and cold seasons; this SNP may be a useful marker for semen quality in boars. Furthermore, the cell-model established from enriched primitive germ cells has potential for the study of reproduction in mature animals.


Subject(s)
Biomarkers/analysis , Hot Temperature , RNA, Messenger/analysis , Semen/physiology , Spermatozoa/chemistry , Swine , 5' Untranslated Regions/genetics , Animals , Heat-Shock Proteins/genetics , Male , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Testis/cytology
9.
Br J Dermatol ; 158(3): 592-6, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18070211

ABSTRACT

BACKGROUND: Hand-foot skin reaction is a distinctive cutaneous side-effect of antineoplastic kinase inhibitor-targeted therapy. Severe hand-foot skin reaction requires postponement of treatment or dose reduction. Histopathological studies of skin toxicity associated with kinase inhibitors are currently unavailable. OBJECTIVES: To report the clinical and histopathological findings of hand-foot skin reaction produced by the multikinase inhibitor sorafenib. METHODS: Nine patients with metastatic carcinoma-seven with renal cell carcinoma (RCC), one with melanoma and one with hepatocellular carcinoma (HCC)-received continuous, oral sorafenib 400 mg twice daily. Hand-foot skin reaction was defined and graded according to National Cancer Institute Common Toxicity Criteria 3.0. Biopsies from lesions of erythematous scaly or blistering skin were obtained from five cases (four RCC and one HCC). RESULTS: Seven of the nine (78%) patients developed hand-foot skin reaction characterized by well-demarcated, tender, erythematous papules and plaques with greyish blisters or hyperkeratotic, callus-like formations on palmoplantar surfaces and distal phalanges. Skin biopsy of hand-foot skin reaction lesions revealed epidermal acanthosis, papillomatosis, parakeratosis, dispersed dyskeratotic cells and keratinocyte vacuolar degeneration. Other skin toxicities included angular cheilitis, seborrhoeic dermatitis and perianal dermatitis. CONCLUSIONS: The clinical manifestations and histopathological features of sorafenib-induced skin reactions are unique. The most relevant histopathological findings of hand-foot skin reaction include keratinocyte vacuolar degeneration, the presence of intracytoplasmic eosinophilic bodies, and intraepidermal blisters in the stratum malpighii. Further studies are warranted to elucidate the mechanisms of this novel multitargeted kinase inhibitor-associated skin reaction.


Subject(s)
Benzenesulfonates/adverse effects , Blister/chemically induced , Drug Eruptions/etiology , Foot Dermatoses/chemically induced , Hand Dermatoses/chemically induced , Protein Kinase Inhibitors/adverse effects , Pyridines/adverse effects , Aged , Aged, 80 and over , Benzenesulfonates/administration & dosage , Blister/pathology , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/drug therapy , Drug Eruptions/pathology , Female , Foot Dermatoses/pathology , Hand Dermatoses/pathology , Humans , Kidney Neoplasms/complications , Kidney Neoplasms/drug therapy , Male , Middle Aged , Niacinamide/analogs & derivatives , Phenylurea Compounds , Protein Kinase Inhibitors/administration & dosage , Pyridines/administration & dosage , Sorafenib , Treatment Outcome
10.
Gene Ther ; 15(4): 309-17, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18059504

ABSTRACT

Baculovirus is an emerging gene delivery vector, thanks to a number of unique advantages. Herein, we genetically modified the rabbit articular chondrocytes with a recombinant baculovirus (Bac-CB) encoding bone morphogenetic protein-2 (BMP-2), which conferred high level BMP-2 expression and triggered the re-differentiation of dedifferentiated third passage (P3) chondrocytes in the monolayer culture. The transduced and mock-transduced P3 cells were seeded into porous scaffolds and cultured in either the dishes or the rotating-shaft bioreactor (RSB), a novel bioreactor imparting a dynamic, two-phase culture environment. Neither mock-transduced constructs in the RSB culture nor the Bac-CB-transduced constructs in the static culture grew into uniform cartilaginous tissues. Only the Bac-CB-transduced constructs cultured in the RSB for 3 weeks resulted in cartilaginous tissues with hyaline appearance, uniform cell distribution, cartilage-specific gene expression and considerably enhanced cartilage-specific extracellular matrix deposition, as determined by histological staining, reverse transcription-PCR analyses and biochemical assays. This is the first study demonstrating that combination of baculovirus-mediated growth factor expression and RSB culture synergistically enhanced in vitro creation of cartilaginous tissues from dedifferentiated chondrocytes. Since baculovirus transduction is generally considered safe, this approach represents a viable alternative to stimulate the formation of engineered cartilage in a more cost-effective way than the growth factor supplementation.


Subject(s)
Baculoviridae/genetics , Bioreactors , Bone Morphogenetic Proteins/genetics , Cartilage/growth & development , Genetic Vectors , Transforming Growth Factor beta/genetics , Animals , Bone Morphogenetic Protein 2 , Cell Differentiation , Cell Line , Enzyme-Linked Immunosorbent Assay , Rabbits , Reverse Transcriptase Polymerase Chain Reaction , Tissue Engineering
11.
Gene Ther ; 14(19): 1417-24, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17637796

ABSTRACT

Baculovirus has emerged as a novel vector for in vitro and in vivo gene delivery due to its low cytotoxicity and non-replication nature in mammalian cells, but the applications of baculovirus in the genetic modification of human mesenchymal stem cells (hMSCs) and tissue engineering are yet to be reported. In this study, we genetically engineered hMSCs with a baculovirus (Bac-CB) expressing bone morphogenetic protein-2 (BMP-2). Bac-CB transduction of hMSCs at a multiplicity of infection of 40 triggered effective differentiation of hMSCs into osteoblasts. Supertransduction at day 6 after initial transduction enhanced the BMP-2 expression and further accelerated the in vitro osteogenesis, as confirmed by alkaline phosphatase assay, Alizarin red staining and reverse transcription-polymerase chain reaction analysis of osteoblastic genes. Implantation of the supertransduced cells at ectopic sites in the nude mice resulted in efficient cell differentiation into osteoblasts at week 2 and induced progressive mineralization and partial bone formation at week 6, as confirmed by hematoxylin and eosin, immunohistochemical and Alizarin red staining. These data collectively demonstrated, for the first time, the potential of baculovirus in hMSCs engineering and implicated its use in bone tissue engineering.


Subject(s)
Baculoviridae/genetics , Bone Morphogenetic Proteins/genetics , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Mesenchymal Stem Cells/metabolism , Transduction, Genetic/methods , Transforming Growth Factor beta/genetics , Animals , Biomarkers/analysis , Bone Morphogenetic Protein 2 , Bone Morphogenetic Proteins/metabolism , Cell Differentiation , Female , Genetic Vectors/genetics , Humans , Immunohistochemistry , Mesenchymal Stem Cell Transplantation , Mice , Mice, Nude , Osteoblasts/cytology , Osteoblasts/metabolism , Osteocalcin/genetics , Osteogenesis , Osteopontin/genetics , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Staining and Labeling , Transforming Growth Factor beta/metabolism
12.
Genet Couns ; 18(1): 49-56, 2007.
Article in English | MEDLINE | ID: mdl-17515300

ABSTRACT

We present prenatal diagnosis of mucopolysaccharidosis type II (MPS II) (Hunter syndrome) and demonstrate marked mucopolysaccharide deposition in multiple vital organs in a 22-gestational-week affected fetus. Level II ultrasound showed cardiomegaly and hepatomegaly. Histological examinations of the fetal vital organs manifested marked mucopolysaccharide deposition. We suggest that any therapeutic approach and counseling for prenatally diagnosed MPS II should consider the early signs of in utero marked mucopolysaccharide storage.


Subject(s)
Genetic Counseling , Mucopolysaccharidosis II/diagnosis , Prenatal Diagnosis , Aborted Fetus/pathology , Abortion, Induced , DNA Mutational Analysis , Female , Glycoproteins/genetics , Glycosaminoglycans/analysis , Humans , Male , Mucopolysaccharidosis II/diagnostic imaging , Mucopolysaccharidosis II/embryology , Mucopolysaccharidosis II/pathology , Mutation, Missense , Pregnancy , Pregnancy Trimester, Second , Ultrasonography, Prenatal
13.
Anim Reprod Sci ; 100(1-2): 158-71, 2007 Jul.
Article in English | MEDLINE | ID: mdl-16876343

ABSTRACT

This study investigated the relationship between serum protein levels and egg productivity in Taiwan red-feathered country chickens (TRFCC). The total egg numbers of TRFCC (n=157) were recorded from 25 to 48 weeks of age. Serum samples were collected at 24 and 35 weeks of age, then classified by total egg number into four groups according to mean+/-1S.D. Serum X protein levels were evaluated by protein chip technology and with an insulin-like growth factor-I (IGF-I) immunoassay. Other serum proteins (apolipoprotein A-I, ovotransferrin and vitellogenin) were found at different levels between the most productive and the least productive groups of TRFCC, were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were quantified by age. The results showed that levels of vitellogenin were positively correlated with total egg number at 24 and at 35 weeks old (p<0.01). Levels of apolipoprotein A-I and an IGF-1-related marker (termed X protein) in serum at 35 weeks old were correlated with total egg number (p<0.01). Serum ovotransferrin levels remained constant regardless of total egg number. To investigate the concentration differences among the four groups of TRFCC, serum protein levels of each group were analyzed by one-way ANOVA. The results showed that those protein levels, except for ovotransferrin, in the least productive group significantly differed from the other three groups (p<0.05). Although the correlation between those protein levels and the total egg number was not significant at the time of initial egg production, the selection strategy of those protein levels at later stages of egg production should provide a screening model to improve selection.


Subject(s)
Blood Proteins/metabolism , Chickens/blood , Oviposition/physiology , Aging , Animals , Chickens/metabolism , Color , Electrophoresis, Polyacrylamide Gel/veterinary , Feathers/physiology , Female , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/veterinary , Taiwan
14.
Eur J Clin Nutr ; 60(1): 136-41, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16234843

ABSTRACT

Infant formulas are often heat sterilized in hospitals where water contamination or nosocomial infection is a concern, but there are few studies of the effect of high heat on the nutritional value of infant formula. In particular, the effect of heat sterilization on free amino acid (FAA) concentrations is seldom discussed. In view of the importance of these nutrients for infant growth, we investigated the FAA concentrations of infant formula after heat sterilization. Powdered infant formulas were reconstituted with hot water (80 degrees C) in glass bottles and placed in an autoclave for 5 min at 105 degrees C and 5600 kg/m2 of pressure. Additional samples of formula were prepared by conventional methods to serve as controls. After autoclaving, we measured the FAA concentrations with ion exchange chromatography. The results were compared with those obtained after conventional preparation. We found a 19.5% lower amount of total protein after autoclaving compared with conventional preparation. Concentrations of total FAA were significantly lower after autoclaving (696.5 +/- 101.4 vs 899.4 +/- 152.2 micromol/l, P = 0.01). The concentrations of individual amino acids were also lower in autoclaved infant formulas, with differences ranging from -4.1 to 71.5% (mean 22.6%). Concentrations of certain amino acids were more than 30% lower, such as valine (71.5%), citrulline (61.1%), glutamine (60.6%), ethanolamine (54%), and lysine (39.2%). Both essential and nonessential amino acids were similarly affected by autoclaving, 28.17 and 27.13%, respectively, lower than in controls (P = 0.37). The concentration of ammonia was significantly higher after autoclaving (645.2 +/- 76.2 vs 393.2 +/-140.7 micromol/l, P = 0.0003). However, the urea level was significantly lower after autoclaving than after conventional preparation (1110.8 +/- 162.7 vs 1426.5 +/- 209.5 micromol/l, P = 0.0004). The accumulation of ammonia may reflect degradation of protein and amino acids. Autoclaving clearly results in decreased concentrations of FAA in infant formula. The increased concentration of ammonia after autoclaving is of concern if it leads to deleterious effects.


Subject(s)
Amino Acids/analysis , Food Handling , Hot Temperature/adverse effects , Infant Formula/chemistry , Infant Nutritional Physiological Phenomena , Ammonia/adverse effects , Ammonia/analysis , Chromatography, Ion Exchange/methods , Humans , Infant , Infant Formula/standards , Infant, Newborn , Nutritive Value
15.
Arch Androl ; 51(6): 419-24, 2005.
Article in English | MEDLINE | ID: mdl-16214726

ABSTRACT

Prostate stromal sarcoma is quite rare, comprising only 0.1-0.2% of all prostate cancers. Here, we report one case of prostate stromal sarcoma in a 38-year-old man. Initially, the patient suffered from lower urinary tract symptoms, and intravenous pyelography showed a larger filling defect in the bladder. Transrectal ultrasound showed a huge heterogenous mass between the bladder and rectum. Abdominal computed tomography revealed prostate tumor with local invasion. Radical cystoprostatectomy with ileal conduit was performed; pathology revealed high-grade prostate stromal sarcoma with invasion to the right seminal vesicle and urethra. This article describes the pathology and immunohistrochemical features of this case and briefly reviews the literature.


Subject(s)
Prostatic Neoplasms/pathology , Sarcoma/pathology , Adult , Antigens, CD34/analysis , Combined Modality Therapy , Humans , Immunohistochemistry , Male , Prostatectomy , Prostatic Neoplasms/chemistry , Prostatic Neoplasms/therapy , Sarcoma/chemistry , Sarcoma/therapy
16.
J Inherit Metab Dis ; 28(6): 1146-8, 2005.
Article in English | MEDLINE | ID: mdl-16435211

ABSTRACT

There is little information about MPS I-related complications during laronidase therapy. We describe the first autopsy report of a young male MPS I patient who died of infection-induced cardiopulmonary failure following 2 years of weekly treatment with laronidase.


Subject(s)
Iduronidase/therapeutic use , Mucopolysaccharidosis I/drug therapy , Mucopolysaccharidosis I/mortality , Adult , Autopsy , Fatal Outcome , Glycosaminoglycans/metabolism , Heart Failure , Heparitin Sulfate/metabolism , Humans , Iduronidase/chemistry , Iduronidase/deficiency , Infections/mortality , Male , Pharmaceutical Preparations , Recombinant Proteins/therapeutic use
17.
Eur J Gynaecol Oncol ; 25(6): 739-41, 2004.
Article in English | MEDLINE | ID: mdl-15597856

ABSTRACT

Recurrent endometrial cancer with both local and distant metastasis is very difficult to treat. A 55-year-old endometrial adenocarcinoma patient with bulky central recurrences and pelvic and inguinal lymph node metastases underwent laparotomy and paraaortic, pelvic and inguinal lymphadenectomy followed by concurrent chemoradiation (with cisplatin) to the paraaortic and inguinal lymph nodes as well as the whole pelvis. Neck and mediastinal lymph node metastasis emerged during treatment. Neck-node radiation and epirubicin was added followed by paclitaxel and carboplatin. Complete remission was achieved. Ten months later, isolated central re-recurrence happened and total pelvic exenteration was performed. The patient has survived without further recurrence for more than five years after the exenteration. Therefore, a multimodality approach with a combination of radical resection (even pelvic exenteration), radiotherapy and chemotherapy could be offered to well-selected patients with recurrent endometrial cancer despite out-of-field progression during therapy and in-field local failure to initial salvage treatment.


Subject(s)
Adenocarcinoma/diagnosis , Endometrial Neoplasms/diagnosis , Neoplasm Recurrence, Local/diagnosis , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Combined Modality Therapy , Diagnosis, Differential , Endometrial Neoplasms/diagnostic imaging , Endometrial Neoplasms/drug therapy , Endometrial Neoplasms/pathology , Endometrial Neoplasms/surgery , Female , Humans , Lymphatic Metastasis , Middle Aged , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery , Salvage Therapy , Tomography, X-Ray Computed
18.
Transplant Proc ; 36(7): 2150-1, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15518780

ABSTRACT

INTRODUCTION: Renal transplantation has been advocated as the treatment of choice for end-stage renal disease. Organ transplantation increases the incidence of cancer through unclear mechanisms. A literature review showed that the most common neoplasms are of skin origin, which are uncommon in Eastern people. We reviewed cancer patterns in our renal transplant series. MATERIALS AND METHODS: From July 1981 to December 2002, among 560 renal transplantations performed in this hospital, we retrospectively surveyed cancer incidence, types, and usage of immunosuppressants. RESULTS: Twenty nine cancer cases 5.18% (incidence) included hepatocellular carcinoma (HCC) as the highest mortality rate (9 of 13 cases). Eight of these 13 cases were hepatitis B carriers. All four hepatitis C carriers expired three of them with unresectable multinodular tumors at diagnosis in Posttransplantation lymphoproliferative disorder (PTLD) was the second most common cancer (seven cases); all but one survived with reduced doses of or changes in immunosuppressants. No skin cancer other than four Kaposi's sarcomas with skin manifestations was detected in our series. DISCUSSIONS: HCC was the main cancer in our series. Accepting hepatitis B carriers as candidates for renal recipients and donors may be one of the causes. PTLD was the second most common cancer, while there were no skin cancers.


Subject(s)
Kidney Transplantation/adverse effects , Neoplasms/epidemiology , Adult , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/mortality , Female , Follow-Up Studies , Humans , Liver Neoplasms/epidemiology , Liver Neoplasms/mortality , Male , Postoperative Complications/epidemiology , Retrospective Studies , Taiwan , Time Factors
19.
BJU Int ; 93(4): 495-8, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15008716

ABSTRACT

OBJECTIVE: To explore a possible correlation of Epstein-Barr virus (EBV) infection with urothelial tumours, as the mutation of oncogenes, inactivation of tumour suppressor genes and viral infections may be important in the tumorigenesis of urothelial tumours, and EBV has been implicated in the pathogenesis of a variety of lymphoproliferative disorders and several epithelial neoplasms. MATERIALS AND METHODS: In all, 104 surgical specimens of transitional cell carcinoma (TCC) were obtained from urological operating rooms, fixed in 10% buffered formalin and processed for in situ hybridization using DNA probes, to locate the signal of EBV-encoded RNAs (EBERs). Immunohistochemistry with antibodies against CD20 and EBV-encoded latent membrane protein-1 (LMP-1) was used on EBER-positive tumour specimens. RESULTS: Thirty-one tumour specimens were positive for EBER hybridization in 100 evaluable specimens. Of these positive specimens, 21 were positive in both the infiltrating B lymphocytes and TCC tumour cells, seven only in B lymphocytes and three only in TCC cells. Of 31 EBER-positive tumour tissues, 26 (84%) had LMP-1, suggesting that EBER is more sensitive than LMP-1 for detecting EBV infection. CONCLUSION: There is a strong association between EBV infection and a significant proportion of primary urothelial TCC tumour cells.


Subject(s)
Carcinoma, Transitional Cell/virology , Epstein-Barr Virus Infections/complications , Urologic Neoplasms/virology , Herpesvirus 4, Human/genetics , Humans , Immunohistochemistry , RNA, Viral/metabolism
20.
J Endocrinol ; 179(3): 387-94, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14656208

ABSTRACT

An anaplastic thyroid cancer cell line, Thena, was recently established in our laboratory following radical thyroidectomy of a patient with anaplastic thyroid cancer. Microscopically, Thena cells were spindle-shaped or small round cells. Thena cells were reactive with cytokeratin AE1/AE3 antibodies, epithelial membrane antigen, interleukin (IL)-6, epithelial growth factor receptor, transforming growth factor (TGF)-alpha, vascular endothelial growth factor, and vimentin. Thena cells secreted high levels of IL-6, leukemia inhibitor factor (LIF), tumor necrosis factor (TNF)-alpha, and TGF-beta1 in the culture supernatants, as determined by enzyme-linked immunosorbent assay. When subcutaneously injected with Thena cells, athymic nude mice developed tumor masses in the skin within 2 weeks. Furthermore, Thena cells induced cachexia in these tumor-bearing mice. High levels of human IL-6, LIF and TGF-beta1 were detected in the mouse sera. To our knowledge, the Thena cell line is the first thyroid cancer cell line reported to induce cachexia in nude mice. This cachectic animal model is worthy of further study to explore the treatment of thyroid cancer-induced cachexia.


Subject(s)
Cachexia/etiology , Cytokines/biosynthesis , Thyroid Neoplasms/complications , Aged , Animals , Cachexia/metabolism , Cachexia/pathology , Disease Models, Animal , Female , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Thyroid Neoplasms/metabolism , Thyroid Neoplasms/ultrastructure , Thyroidectomy , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...